US 11440939
Anticancer peptides
granted A61KA61K38/00A61K47/62
Quick answer
US patent 11440939 (Anticancer peptides) held by IDP DISCOVERY PHARMA, S.L. expires Mon Sep 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- IDP DISCOVERY PHARMA, S.L.
- Grant date
- Tue Sep 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K38/00, A61K47/62, A61P, A61P35/00